Podcasts about Digital health

Breakthrough blood tests that can flag dozens of cancers before symptoms appear are gaining momentum, yet questions remain about accuracy, equity, and how these tools will fit into routine care.In this episode, Steve talks with Helmy Eltoukhy, co-founder and co-CEO of Guardant Health, a $14 billion publicly-traded precision oncology company. The conversation explores the science behind cell-free DNA, the rise of blood-based cancer screening, and the broader shift toward data-driven diagnostics.We cover:How liquid biopsy works and why cell-free DNA became such a powerful toolThe path from late-stage applications to large-scale early detectionWhat Medicare coverage of blood-based colorectal cancer screening signals for adoptionThe operational and regulatory hurdles that shape diagnostics businessesLessons from Helmy's entrepreneurial path across sequencing, diagnostics, and company-building—About our guest: Helmy Eltoukhy is the chairman and co-CEO of Guardant Health, a leading precision oncology company he co-founded in 2012. He is also an active investor and is involved in over 30 startup companies across the technology and healthcare sectors. In December 2024, Eltoukhy expanded his ventures into sports ownership by co-leading the acquisition of Sheffield United Football Club through COH Sports of which he is currently co-chairman.Last year, he was named by TIME100 Health as one of the most influential people in global health. He was also on Time Magazine's inaugural list of the 50 Most Influential People in Health Care and has been recognized by Fortune (40 under 40), the World Economic Forum (Technology Pioneer), and on the list of the Top 50 Healthcare CEOs in 2021.Beyond his entrepreneurial endeavors, Eltoukhy is deeply committed to various philanthropic efforts and serves on the boards of the Prostate Cancer Foundation, the SETI Institute (Search for Extraterrestrial Intelligence), and the UCSF Cancer Leadership Council. Prior to founding Guardant Health, Eltoukhy co-founded Avantome in 2007 to commercialize semiconductor sequencing, which was later acquired by Illumina. Eltoukhy is a named inventor on over 100 patents and holds PhD, MS, and BS degrees in electrical engineering from Stanford University.—Learn more about the Rock Health CEO Summit at the New York Stock Exchange on March 27th.—

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Aaron Sheedy, COO at Xealth.What you'll get out of this episode:Building Xealth with health system partners: Early validation from Providence and other major systems helped shape a scalable integration platform for digital health tools.Improving patient readiness through digital engagement: Sending timely pre- and post-visit information dramatically improves patient preparation, including a 42% increase in MRI appointment readiness.Reducing friction in patient communication: Portal-adjacent access allows patients to view care instructions without logging into traditional patient portals, driving significantly higher engagement.Samsung's healthcare vision: With devices already in millions of homes, Samsung aims to use wearable data and home technology to connect patients to the right care at the right time.Digital health strategy beyond the EHR: Health systems relying solely on their EHR for digital health risk lacking a true digital strategy and differentiation.To learn more about:Website https://www.xealth.com/Linkedin http://www.xealth.comOur sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Dr. Barbara Paldus is the Founder and CEO of CODEX Labs, the sponsor of this episode.She grew up around Nobel Prize winners, built biotech manufacturing equipment for vaccines and cancer therapeutics, and then sold her company after an 8 year old threatened suicide.Her son's severe eczema pushed her into an unregulated $100,000,000,000 skincare market where parents are told to trust labels that nobody verifies. She explains how corticosteroid ladders leave patients with years long withdrawal, why U.S. ingredient oversight lags Europe, and how chemotherapy destroys the same skin and gut barriers seen in inflammatory disease.The conversation tracks the real stakes behind “clean” marketing: a child's immune system, hospital infections like MRSA, and patients trying to survive treatment without new damage. She also details the research path from Irish medical manuscripts to microbiome science and why sick populations become the only reliable regulators when policy fails.RELATED LINKSBarbara PaldusCodex LabsSekhmet VenturesDr Peter LioFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

We've had many conversations on Raise the Line about the challenges of health communication in today's world of information overload, but none of our guests have the kind of expertise Dr. Tesfa Alexander has acquired in a career that has taken him from Madison Avenue to the halls of government and academia. From guiding tobacco education research at the FDA to leading public health initiatives at MITRE, Dr. Alexander has developed a deep understanding of the science and strategy behind effective health communication. “Successful campaigns keep the long game in mind where you want to develop a lasting relationship with your target audience,” he tells host Lindsey Smith. That relationship needs to be built on understanding culture, beliefs, priorities and daily realities, and only then can you develop messaging that will resonate, he explains. Dr. Alexander also believes these relationships can be leveraged to help people sort out facts from misleading or inaccurate claims. “I strongly recommend shifting our focus from combating misinformation head on, and instead working with the communities who we are seeking to serve.” This fascinating look at communication science also covers: How stories drive belief; The importance of working with community partners who are trusted messengers;  The power of audience segmentation. Tune in as Dr. Alexander unpacks what it takes to influence beliefs, and ultimately behaviors, in an era defined by misinformation and institutional mistrust. Mentioned in this episode:Lerner Center for Public Health Advocacy If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Dr Eugene Manley grew up in Detroit in the 1980s cycling through emergency rooms 20 to 30 times a year with asthma and anaphylaxis while hospital staff talked past his family and buried them in paperwork they could not decode. He responded by earning a BS in mechanical engineering an MS in biomedical engineering and a PhD in molecular biology cell biology and biochemistry. Along the way he tore his ACL training for a jiu jitsu black belt worked 86 straight days in a lab during his doctorate and learned how academic and clinical systems punish people who refuse to shrink.In this episode Manley walks through a recent post surgery ordeal at Mount Sinai Queens where staff falsified records attempted an illegal discharge and nearly sent him home on the wrong blood thinner. He explains how medical racism shows up in charts staffing and decision making and why measurable equity fails without accountability. Listeners hear how his STEMM and Cancer Health Equity Foundation builds pipelines for underrepresented students challenges clinical trial design and teaches patients how to protect themselves when institutions lie. RELATED LINKS• Eugene Manley Jr• STEMM and Cancer Health Equity Foundation• Village Voice• LUNGevity FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“Show me an incentive structure and I'll show you human behavior... until employers realize they have more power than they give themselves credit for, this can't continue."My guest this week is Norm Volsky, Managing Partner at DRI and Founder of MVP Growth Partners. Norm has spent the last decade as one of the top executive recruiters in the digital health and employer benefits space - placing the commercial teams that helped build unicorns like Livongo and Hinge Health.In this episode, Norm explains why the next wave of healthcare innovation isn't about adding more "point solutions" to an already fatigued market. Instead, smart money is betting on companies that carve out high-margin, inefficient services directly from the major insurance carriers - like radiology, fertility, and specialty infusion.We discuss how Norm built an "army" of over 500 industry executives to crowdsource due diligence, why the traditional VC model fails in healthcare, and why employers and their benefits leaders are finally at a watershed moment where they must demand true fiduciary alignment from their vendors.If you want to know where the smart money is moving in employer healthcare, and why the "BUCA" carriers should be worried, this episode is a must-listen.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit ParetoHealth.com to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:[00:00:00] Intro: Recruiting in the Early Days of Digital Health[00:04:12] The Livongo Story: Selling Healthcare Direct to Employers[00:08:44] What Makes a Great Salesperson in Healthcare?[00:11:46] Spotting the Next Unicorn: The Hinge Health Experience[00:17:28] Private Equity vs. Venture Capital[00:20:00] Using Recruitment Data to Drive VC Investments[00:23:41] The "One Imaging" Pitch & Carving Out Radiology[00:30:40] Building an Army: Crowdsourcing VC Due Diligence[00:36:26] Why MVP Growth Partners Only Invests in "At-Risk" Pricing[00:41:40] Point Solution Fatigue & Identifying the "Good Actors"[00:46:17] Why Employers Must Demand Fiduciary Responsibility[00:50:41] The Future: The Erosion of the Big 3 PBMs and CarriersKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

“Show me an incentive structure and I'll show you human behavior... until employers realize they have more power than they give themselves credit for, this can't continue."My guest this week is Norm Volsky, Managing Partner at DRI and Founder of MVP Growth Partners. Norm has spent the last decade as one of the top executive recruiters in the digital health and employer benefits space - placing the commercial teams that helped build unicorns like Livongo and Hinge Health.In this episode, Norm explains why the next wave of healthcare innovation isn't about adding more "point solutions" to an already fatigued market. Instead, smart money is betting on companies that carve out high-margin, inefficient services directly from the major insurance carriers - like radiology, fertility, and specialty infusion.We discuss how Norm built an "army" of over 500 industry executives to crowdsource due diligence, why the traditional VC model fails in healthcare, and why employers and their benefits leaders are finally at a watershed moment where they must demand true fiduciary alignment from their vendors.If you want to know where the smart money is moving in employer healthcare, and why the "BUCA" carriers should be worried, this episode is a must-listen.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit ParetoHealth.com to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:[00:00:00] Intro: Recruiting in the Early Days of Digital Health[00:04:12] The Livongo Story: Selling Healthcare Direct to Employers[00:08:44] What Makes a Great Salesperson in Healthcare?[00:11:46] Spotting the Next Unicorn: The Hinge Health Experience[00:17:28] Private Equity vs. Venture Capital[00:20:00] Using Recruitment Data to Drive VC Investments[00:23:41] The "One Imaging" Pitch & Carving Out Radiology[00:30:40] Building an Army: Crowdsourcing VC Due Diligence[00:36:26] Why MVP Growth Partners Only Invests in "At-Risk" Pricing[00:41:40] Point Solution Fatigue & Identifying the "Good Actors"[00:46:17] Why Employers Must Demand Fiduciary Responsibility[00:50:41] The Future: The Erosion of the Big 3 PBMs and CarriersKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

Pharma ads, biotech IPOs, $1M longevity programs, oh my!This month's Digital Health Download skews towards biotech, which is having a moment. Tune in to hear Halle and Michael cover the latest headlines.We cover:Why pharma ads are surging and the growing push for restrictions on D2C drug advertisingHims & Hers' $1.15B acquisition of Eucalyptus, its global expansion strategy, and the FDA crackdown on compounded GLP‑1 drugsThe return of biotech IPOs, with Eikon Therapeutics and Generate Biomedicines signaling investor interest in platform‑based drug discoveryVaccine makers scaling back research amid policy uncertainty, declining uptake, and tighter fundingTrumpRx's “most favored nation” drug pricing approach, and what one STAT analysis foundBryan Johnson's $1M per year “Immortals” longevity program—Show notes:Should drug companies be advertising to consumers? (The New York Times) Hims & Hers Enters $1.15 Billion Agreement to Acquire Eucalyptus (PharmExec.com)A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all (STAT)Vaccine Makers Curtail Research and Cut Jobs (The New York Times) TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics (STAT)Bryan Johnson's Immortals: $1M to try longevity regimen (Axios) —"Halle Tecco wanted to see tech used for better medical services and getting people engaged in their own health. Now, she's written a book on how she went about it." - The WSJMassively Better Healthcare is out now!—Rock Health's annual CEO Summit is returning to the New York Stock Exchange on March 27th! Learn more and nominate a CEO to join this invite-only event here. —

Jennifer Goldsack has built a career in digital medicine, and she's doing it while navigating late-stage cancer herself. As founder and CEO of the Digital Medicine Society (DiMe), Jennifer is leading efforts to ensure digital health technologies are safe, effective, and equitable. In this episode, she shares how her journey as an Olympian, data nerd, and patient shapes her mission to transform health care. The hosts discuss the real-world challenges of implementing digital medicine, the policy landscape shaping innovation, and why patient-centered design must remain at the core of technological advancement. This conversation is both deeply personal and forward-looking; a powerful reminder that the future of medicine must work for the people it serves.

Jessica from SomX chat through all the best news from this week with Christoph Ruedig from Albion VC and Celestin de Wergifosse from Signatur Bio.

Part II: How Telehealth is Redefining Clinical Practice and Patient Access Join us for part two of a two-part interview with Dr. Brandon Welch, founder and CEO of doxy.me; a platform that has facilitated over 8 billion minutes of care across 1 million providers in 176 countries. With the administration signing the Consolidated Appropriations Act on February 3, 2026, extending Medicare telehealth flexibilities through December 2027, and patient demand driving unprecedented adoption, virtual care has moved from emergency response to fundamental transformation of clinical practice. Brandon examines how the proliferation of telehealth is reshaping medicine itself: clinical workflows, patient-provider relationships, access equity, and sustainable practice models. Drawing from his book Telehealth Success, he delivers actionable strategies for healthcare leaders navigating the five pillars determining telehealth ROI: patient engagement, clinician efficiency, technology scalability, financial viability, and regulatory compliance in an era where patients expect care everywhere. • Five-pillar framework for achieving sustainable telehealth success across organizations • Financial sustainability models leveraging the two-year Medicare telehealth extension through 2027 • Clinical practice transformation reshaping how medicine is delivered and experienced • Provider success strategies addressing burnout, workflow integration, and practice transformation • Access and equity insights from 176-country, 1 million+ provider implementation Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Heart disease should be treated just like cancer, says guest Mike McConnell, an author and expert in preventive cardiology at Stanford: Detect and stage early, then treat aggressively. In his practice, McConnell focuses on using low-dose CT imaging for detecting early coronary artery disease. He also helped pioneer the use of AI to infer cardiovascular risk from retinal scans. Such non-invasive, consumer-friendly tools could expand prevention, personalize therapy, and cut heart attacks and strokes across the board, he says. “Everybody also deserves a proactive preventive cardiologist in their phone,” McConnell tells host Russ Altman of the latest approaches to heart disease on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Michael V. McConnell, MD, MSEE Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Michael McConnell, a professor of cardiology at Stanford University. (00:03:02) Reframing Heart Disease Why coronary disease should be approached the same as cancer. (00:05:46) Core Risk Factors The key drivers of cardiovascular disease, and life's essential eight. (00:07:18) Coronary Artery Calcium Scoring How low-dose CT scanning detects disease before symptoms develop. (00:08:57) The Limits of Stress Testing Why traditional stress tests often miss early coronary disease. (00:10:18) AI in Cardiac Imaging Using AI to identify hidden risks in routine chest scans. (00:11:30) Retinal Imaging How AI analysis of retinal blood vessels can predict heart disease risk. (00:14:55) Detecting Risk Before Symptoms Why retinal and vascular changes occur long before clinical signs appear. (00:15:58) Staging Coronary Disease Using calcium scores to stage coronary disease and personalize treatment. (00:19:36) Direct-to-Consumer Prevention The rise of mobile health records, wearable devices, and AI tools. (00:22:23) Opportunities & System Challenges Balancing accessibility, guideline-based care, and healthcare system capacity. (00:25:26) AI-Powered Health Record Analysis The potential of automated reviews to identify silent risk factors. (00:27:41) Physician Adoption & System Friction Barriers to integrating early detection tools into clinical practice. (00:30:12) Advances in Treatment Overview of current cholesterol therapies and plaque stabilization. (00:33:31) Future In a Minute Rapid-fire Q&A: prevention, implementation science, and future hopes. (00:35:38) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send a textDr. Ben Hwang, Ph.D. is Chairman and CEO of Profusa ( https://profusa.com/ ), a pioneering bioengineering company developing tissue-integrated biosensors designed to continuously measure key chemical markers within the body. Profusa's mission is to make our body's chemistry as accessible as heart rate or step count — transforming personal and societal health through real-time molecular insight.Dr. Hwang has spent his career at the frontier where life science tools, digital systems, and global markets intersect. As an undergraduate research fellow in the laboratory of systems biology pioneer Leroy Hood at California Institute of Technology, he witnessed firsthand how transformative technologies can redefine biology.Dr. Hwang later held multiple senior leadership roles at Life Technologies (now part of Thermo Fisher Scientific), including President of Asia Pacific and Head of the qPCR Division — helping scale molecular biology platforms globally during a pivotal period for genomics and diagnostics.Earlier in his career, Dr. Hwang worked at McKinsey & Company and even began in professional sports with the Los Angeles Dodgers — an unusual trajectory that informs his leadership perspective today.Dr. Hwang earned his M.A. and Ph.D. in Biology from Johns Hopkins University.#DigitalHealth #Longevity #Biosensors #ContinuousMonitoring #FutureOfMedicine #HealthcareInnovation #WearableTech #Biotechnology#PrecisionMedicine #HumanOptimization #HealthTech #PreventiveMedicine#AgingResearch #Biohacking #MedicalInnovation #MetabolicHealth #Hypoxia #Mitochondria #ChronicDisease #FutureOfHealthcareSupport the show

We're marking Rare Disease Month 2026 by highlighting the powerful story of Shanthi Hegde, a young patient advocate working to transform how bleeding disorders are understood, treated, and supported. This work is fueled by her own arduous journey with two rare bleeding disorders and immune dysregulatory syndrome, and an extended diagnostic odyssey marked by dismissal, underdiagnosis, and structural bias. “I was told many times by many providers that these disorders are not common in Indians and that my bruises were there just because I'm brown.” Admirably, Shanthi pushed past this mistreatment, advocated for her medical needs, and devoted herself to tackling a range of issues confronting rare disease patients from mental health access to affordable drug pricing to research equity. In this remarkable Year of the Zebra conversation with host Lindsey Smith, you'll also learn about: Shanti's work with the Hemophilia Federation of America; How gaps extend beyond treatment to include insurance coverage, provider training, and substance use care; What clinicians can do to improve the work they do with rare disease patients. Join us for a conversation that connects patient voice to system change, and explores what real equity for rare disease communities will require. Mentioned in this episode:Hemophilia Federation of AmericaShanthi's LinkedIn Profile If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. Jordi Piera Jiménez joins Pulse to unpack the foundations of digital health.Fresh from stepping down as Director of Digital Health Strategy at the Catalan Health Service, Jordi reflects on what most health systems are still getting wrong: interoperability that's more theatre than reality, AI built on poorly structured clinical data, and the dangerous confusion of digital transformation with IT procurement.We explore why public health systems should own their digital infrastructure, how procurement can be a powerful lever for change, and why clinicians must be better supported to understand that documentation is the core of modern healthcare.Jordi shares a bold vision for the next decade: true digital public infrastructure, genuine patient agency over data, and platform economies that drive innovation without vendor lock-in.A thoughtful, systems-level conversation about infrastructure, governance, ethics — and getting the foundations right.Connect with Jordi: LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Denmark has been a digital health frontrunner for over two decades. In this episode, recorded live in Barcelona, Morten Elbæk Petersen, CEO of sundhed.dk, shares how Denmark launched its national patient portal in 2002 — long before most European countries began digitizing patient access. Now, as Denmark prepares for a major health reform culminating in the establishment of Digital Health Denmark in 2027, the country is modernizing legacy systems, strengthening cybersecurity, integrating secondary data, and shifting care from hospitals to homes. This conversation explores what long-term digital maturity really means — the benefits, the legacy challenges, and the governance reforms shaping Denmark's next chapter.

Jenny Opalinski has spent more than a decade inside hospitals where people lose the ability to speak, breathe, swallow, and sometimes survive. A medical speech language pathologist by training, she worked in ICU, neuro rehab, and long term acute care settings, including a Level 1 trauma center, where she watched clinicians absorb 10 to 15 traumatic events in a single shift and then get told to move the crash cart faster next time.That lived reality pushed her to co found The Wellness Shift, an advocacy and education platform focused on healthcare worker burnout, suicide, and assault. In this conversation, Opalinski walks through the moment that changed everything for her: standing in a hospital hallway listening to a family wail after a failed code, followed by a debrief that addressed logistics and ignored grief entirely.She also explains how that work led to Humanity Rx, her podcast about the human cost of medicine, and Dragon's Breath: Calming Tricks for Big Feelings, a children's book that translates evidence based breathing and regulation strategies into language kids can actually use. The episode covers moral injury, time scarcity, false wellness, respiratory muscle training, and why empathy keeps getting treated as an optional expense instead of clinical infrastructure.RELATED LINKSJenny Opalinski on LinkedInThe Wellness ShiftHumanity RxDragon's Breath: Calming Tricks for Big FeelingsAspire Respiratory ProductsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and data were shaping cancer care, pushing the serial entrepreneur to build a different model.Lefkofsky is the founder and CEO of Tempus, now a $10B publicy traded health tech company, and previously founded Groupon. At Tempus, he's building a tech-first company applying multimodal data and AI to make diagnostics smarter and treatment decisions more tailored, starting in oncology and expanding across disease areas.We cover:What Tempus does in plain EnglishWhy Tempus built its own lab, and how it became one of the largest sequencers of cancer patients in the U.S.The hard part: extracting usable clinical data from EHRs and scaling to thousands of hospital connections and hundreds of petabytes of dataHow AI changes the patient-physician relationship, and why patients will increasingly arrive highly informedWhat Eric would change at CMS and HHS to responsibly pay for AI—About our guest: Eric Lefkofsky is the founder and CEO at Tempus, a leader in artificial intelligence and precision medicine. He is the co-founder and General Partner of Lightbank, a private venture capital firm specializing in investments in technology companies. He is also the co-founder of Pathos AI, a clinical stage biotechnology company focused on re-engineering drug development; Groupon (NASDAQ: GRPN), a global e-commerce marketplace; Mediaocean, a leading provider of integrated media procurement technology; Echo Global Logistics (NASDAQ: ECHO), a technology-enabled transportation and logistics outsourcing firm; and InnerWorkings (NASDAQ: INWK), a global provider of managed print and promotional solutions.He co-chairs the Lefkofsky Family Foundation with his wife Liz to advance high-impact initiatives that enhance lives in the communities served. Lefkofsky also serves on the board of directors of The Art Institute of Chicago and Northwestern Medicine. He holds a bachelor's degree from the University of Michigan and a J.D. from the University of Michigan Law School.—

Reflections on the Peter Attia/Epstein scandal; How to lower lp(a)—does diet help? What are bio-active peptides? Could they stave off kidney disease? Scientists just tested the fittest 81-year-old in the world—here's what they found; Media erroneously report that intermittent fasting is not effective for weight loss; Sugary drinks may stoke anxiety in teens; Omega-3s support kids' reading fluency and spelling scores; Surprising study shows saturated fats not harmful to kidneys.

In this episode, Girish N. Nadkarni, Chair of the Windreich Department of Artificial Intelligence and Human Health, Director of the Hasso Plattner Institute for Digital Health, and Chief AI Officer, and Nicholas Gavin, MD, MBA, MS, Vice President and Chief Clinical Innovation Officer at Mount Sinai Health System, discuss building AI governance and assurance frameworks, expanding asynchronous care, and using generative AI to improve access, efficiency, and patient centered innovation.

Part I: How Telehealth is Redefining Clinical Practice and Patient Access Join us for part I of a two-part interview with Dr. Brandon Welch, founder and CEO of doxy.me; a platform that has facilitated over 8 billion minutes of care across 1 million providers in 176 countries. With the administration signing the Consolidated Appropriations Act on February 3, 2026, extending Medicare telehealth flexibilities through December 2027, and patient demand driving unprecedented adoption, virtual care has moved from emergency response to fundamental transformation of clinical practice. Brandon examines how the proliferation of telehealth is reshaping medicine itself: clinical workflows, patient-provider relationships, access equity, and sustainable practice models. Drawing from his book Telehealth Success, he delivers actionable strategies for healthcare leaders navigating the five pillars determining telehealth ROI: patient engagement, clinician efficiency, technology scalability, financial viability, and regulatory compliance in an era where patients expect care everywhere. • Five-pillar framework for achieving sustainable telehealth success across organizations • Financial sustainability models leveraging the two-year Medicare telehealth extension through 2027 • Clinical practice transformation reshaping how medicine is delivered and experienced • Provider success strategies addressing burnout, workflow integration, and practice transformation • Access and equity insights from 176-country, 1 million+ provider implementation Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Health Affairs' Jeff Byers welcomes Christina Farr, CEO and editor-in-chief of Second Opinion Media, back to the pod to discuss her book, The Storyteller's Advantage: How Powerful Narratives Make Businesses Thrive. The conversation explores the value of storytelling in the health care and health policy space, how to invest in posting, the catch 22 of "spicy takes," recommendations for the reluctant poster, and Christina shares a quick look into what's interesting in the digital health investment space. 

Send a textHealthcare has long promised a digital revolution, yet many clinicians feel more burdened than empowered. With AI now accelerating at a rapid pace, can this moment finally deliver on that promise?Dr. Robert Wachter, author of A Giant Leap, joins host John Driscoll to discuss how AI is evolving clinical workflows and decision-making, why "better than human" is good enough in our overburdened system, and the leadership choices that will determine whether AI reduces burnout or deepens healthcare's existing failures.

AI Is Not a Silver BulletRecorded live at APTA CSM, Todd Norwood joins the show to talk about AI, digital health, and why physical therapy clinics need to fix their data before chasing the next shiny tech solution.What We Cover:The difference between good data and bad data in PTWhy “ish” measurements don't scale in an AI worldHow to evaluate AI scribes and clinic toolsImposter syndrome in leadership and tech transitionsHow PT skills translate into digital health rolesUsing AI to assess your resume against job descriptionsWhy investing in yourself beats any market investmentKey TakeawayGood data is foundational to making the most of AI and digital innovation in physical therapy.GuestTodd NorwoodPT in Digital Health

In this episode, Christian Milaster, MS, Founder and CEO of Ingenium Consulting Group, shares how thoughtful implementation, not just new technology, is critical to improving outcomes in rural health. He discusses CMS rural health transformation funding, digital health and AI trends, and why methodology and implementation science are essential to turning innovation into real impact.

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Dan D'Orazio, CEO at Sage Growth Partners.What you'll get out of this episode:Access Program & Fee-for-Service Disruption: New regulatory and payment guidance signals a major shift away from fee-for-service toward market-driven healthcare reform.PBM Reform & Transparency: Accelerating policy changes aim to increase transparency and reshape pharmacy benefit management.AI: From Hype to Practicality: The industry is moving from AI excitement to enterprise-level use cases in clinical, revenue cycle, and administrative workflows.Interoperability & Data Liquidity: Data liquidity remains a central priority, with interoperability still an unresolved industry-wide challenge.The Fax Paradox: Despite AI momentum, fax remains deeply embedded in healthcare workflows—now increasingly moving to the cloud.To learn more about:Website http://www.sage-growth.comLinkedin https://www.linkedin.com/company/sage-growth-partners/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.

Few issues have tested public trust in medicine as deeply as vaccines, and few individuals have influenced that dialogue more than Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia and a longtime member of the FDA's Vaccine Advisory Committee. In this timely and candid interview with Raise the Line host Lindsey Smith, Dr. Offit points to this year's severe flu season and a resurgence of measles as alarming proof points of how a changing federal perspective on vaccine policy is having a real impact on public health. “You'd like to think you can educate about the importance of vaccines, but I fear at this point the viruses themselves are doing the educating.” In this wide ranging discussion, Dr. Offit also addresses: The rigorous and painstaking process of developing vaccines, based on his experience co-inventing the rotavirus vaccine. Shifting levels of public trust in scientific organizations. Promising innovations in vaccine development. Don't miss this deeply-informed perspective on the interplay of science, policy, and public education, and his encouraging message to young clinicians about managing the current challenges in public health.  Mentioned in this episode: Vaccine Education Center at Children's Hospital of PhiladelphiaPerelman School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Sunstone Health CEO Joshua Resnikoff joins Chris Lustrino to explain how Sunstone uses AI on healthcare claims data to proactively identify children with developmental delay—starting with epilepsy and autism—and help families reach the right specialists and diagnostics faster.They break down what claims data is, why the healthcare system is reactive by default, and how Sunstone's approach can compress what often takes years into roughly weeks by flagging high-need cases, coordinating advanced diagnostics, and delivering actionable next steps. Joshua also shares Sunstone's go-to-market strategy (positioned as an employer-paid benefit), why the pricing model is designed to reduce “point-solution bloat,” and how expansion could move across employers, TPAs, reinsurers, and large insurers. 00:00 Needle-in-a-haystack intro03:13 What Sunstone does (AI + claims data)05:32 Flagging patients vs. diagnosing07:21 Employer benefit + privacy model15:54 GTM + sales cycle reality17:57 Outcome-based pricing model20:16 Unit economics ($10k per case)22:11 Expansion paths + other diseases26:23 Fundraise use of proceeds28:03 Investor closing

This week on Pulse: Hot Topics, Louise and George tackle big shifts in medicines safety and the accelerating global AI race in healthcare.Australia moves toward a National Medicines RecordThe Federal Government announces reforms requiring medicines prescribed via online platforms to be uploaded to My Health Record — including clinical context. With medication-related harm accounting for around 250,000 hospital admissions annually, is this the safety infrastructure Australia has needed for decades?AI predicts 130 diseases from one night of sleepA new Nature Medicine study claims a sleep foundation model trained on 585,000 hours of data can predict future risk of more than 130 diseases. Breakthrough preventative medicine — or promising science with important caveats.China's AI healthcare surgeChina's Ant Group health chatbot reaches 30 million monthly users, embedded inside Alipay's super-app ecosystem. Meanwhile, China announces a $2–3 billion national AI healthcare strategy targeting population-scale deployment by 2030. Are we witnessing two divergent AI healthcare futures — cautious and regulated versus centralised and scaled?We are on tour!Charlotte Blease of #DrBot book fame and Louise are hitting the road together. Come see them in person and get your booked signed by Charlotte!Sydney: Tuesday 3rd March 6pm, Gleebooks, Glebe. Get tickets hereMelbourne: Tuesday 10th March 6.30pm, Mary Martin Bookshop, Southbank. Get tickets hereResourcesDr Sara Riggare's Checklist and Resources for Meaningful Engagement of Patients LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Send a textHow can patients and providers trust AI in healthcare if they don't understand how it works? In this clip from our episode "Making Healthcare Access Truly Borderless”, HealthBiz Podcast host David Williams speaks with Dr. Sarah Matt, author of The Borderless Healthcare Revolution, about why explainability and trust matter when AI is used in care delivery.Listen to the full episode here

Sarah Gromko and Matthew Zachary go back to SUNY Binghamton in the early 1990s, when they were barely 19 and living inside rehearsal rooms. She starred in campus musical theater productions. He served as pianist and music director for many of those shows and played rehearsal piano for the THEA101 repertory company. This episode reunites two former theater nerds who grew up and took very different paths through art, illness, and work that still circles the same truth.Gromko trained as a singer and composer, studied film scoring at Berklee College of Music, worked in New York and New Orleans, then moved into healthcare as a speech language pathologist and recognized vocologist. She explains aphasia, apraxia, dysarthria, and dysphagia with clarity earned from the clinic. She recounts helping a 16 year old gunshot survivor in New Orleans speak again using Melodic Intonation Therapy. The conversation covers voice banking for ALS, gender affirming voice care, and the damage caused when medicine confuses speech loss with intelligence loss. The result feels like an epic reunion powered by 1990s nostalgia and sharpened by decades of lived consequence.RELATED LINKSSarah GromkoGramco VoiceMelodic Intonation TherapyFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Faces of Digital Health, Tjaša Zajc speaks with Dale Atkinson, a stage 4 oesophageal cancer patient who was told he had 11.5 months to live—and who is still alive today. Dale shares how he applied his compliance and investigation skills to healthcare: reading thousands of research papers, building a research-grounded AI workflow to sense-check drug interactions and pathways, and learning how to communicate with clinicians to be taken seriously. We discuss patient agency, the doctor–patient relationship, the promise (and risks) of AI for patients, the digital divide in healthcare, and why quality of life must be central to care decisions. Dale also shares how his journey led to new work in patient advocacy, the Beyond the Standard foundation, and the Clear Path Clinic vision for integrative oncology and wellness. Topics include: patient empowerment, AI in patient journeys, evidence-based complementary approaches, healthcare equity, clinician workload, prognosis anxiety, and new patient-led models of care. TIMESTAMPS (CHAPTER-STYLE) * 00:01 Intro: why patient agency matters more as systems strain * 04:12 Dale's story begins: diagnosis after wife's lung cancer + mother's death * 07:22 Stage 4, inoperable, palliative care: the emotional impact * 08:31 Asking for a timeline: why Dale wanted prognosis data * 09:18 How a financial crime investigator becomes a “patient investigator” * 10:55 The deep dive: thousands of papers, books, and expert conversations * 12:09 Where AI enters: building a research-grounded model for sense-checking * 15:00 Standard of care + complementary approach (not “alternative”) * 16:08 Friction with clinical advice; nutrition and chemo trade-offs * 17:48 Choosing treatments based on quality of life and realistic benefit * 20:06 When Dale felt the trajectory could change: from survival to stability * 21:11 Anxiety, recurrence risk, and “no evidence of disease” vs remission * 24:46 Missed symptoms, dismissal, and why patient agency is learned the hard way * 28:32 “Love-hate” to collaborative: a new model for doctor–patient dynamics * 32:16 How to communicate to be heard: bite-sized, stakeholder-specific info * 35:28 Clinicians under pressure: emotional load and “factory line” care reality * 37:58 AI impact in the patient community—and why it's accelerating * 40:27 Digital divide concerns: will digital skills determine outcomes? * 42:36 AI and emotion: pessimism loops, “horror statistics,” and mental safety * 45:02 A new career: Beyond the Standard, Clear Path Clinic, book, advisory work * 49:25 Closing reflections and thanks Video: https://youtu.be/VeIZkRraxWc www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

In this episode (recorded live), Halle Tecco speaks with Dr. Robert Wachter, Chair of Medicine at UCSF, about their concurrently released books on healthcare innovation and AI.They share thoughts on the dual challenge of innovation in healthcare and the role of AI, covering:Why past waves of tech failed to change healthcare and why AI may finally break throughHow AI is making a difference today in healthcareWhere AI-assisted diagnosis and prescribing could go next, and the risks of over-relying on humans “in the loop” How EHR vendors (like Epic) hold the "poll position" for AI implementation due to workflow integrationWhy innovators must become healthcare "anthropologists"; and clinicians must understand technology and AIPlus, a surprise guest from Prenuvo joins us to chime in. Order Halle's new book, Massively Better Healthcare hereOrder Bob's new book, A Giant Leap here—About our guest: Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF). Author of 300 articles and 6 books, he coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest-growing medical specialty in U.S. history. He is a past president of the Society of Hospital Medicine, past chair of the American Board of Internal Medicine, a Master of the American College of Physicians, and an elected member of the National Academy of Medicine. Modern Healthcare magazine has ranked him among the 50 most influential physician-executives in the U.S. more than a dozen times; he was #1 on the list in 2015. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine's Computer Age, was a New York Times bestseller. His new book is A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Karen unpacks the fast-growing world of digital health, from Apple Watch and smartphone apps to telehealth and new hospital tech that can improve care and streamline recovery at home. She also addresses the downsides, raising concerns around the security of these technologies.Visit our website itchyandbitchy.com to read blog posts on the many topics we have covered on the show.

FHIR-Native Architecture: Building Healthcare IT for True Interoperability As healthcare systems race to meet 21st Century Cures Act mandates, a critical question emerges: retrofit or rebuild? Mike O'Neill, CEO of MedicaSoft, explains why FHIR-native architecture delivers fundamentally different interoperability outcomes than legacy systems with API layers bolted on. This conversation cuts through vendor marketing to examine the structural, semantic, and operational advantages of building healthcare IT from the ground up on HL7 FHIR standards. O'Neill draws on extensive experience leading P&L, engineering, and operations across healthcare IT startups and public companies to explain what "FHIR-native" actually means in practice—and why it matters for CIOs evaluating vendor claims. Learn how purpose-built FHIR architecture eliminates middleware complexity, reduces integration costs, and enables real-time clinical data exchange that retrofitted systems struggle to deliver. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Digital health is no longer in its honeymoon phase. The funding boom is over. AI hype is everywhere. Health systems are overwhelmed. And startups can no longer survive on compelling pitch decks alone. In this episode of Faces of Digital Health, Tjaša Zajc speaks with Ruchi Dass, a former dental surgeon turned public health leader, policy contributor, investor, and advisor to startups scaling across the US, UK, India, Africa, and the Middle East. Ruchi describes a fundamental change in go-to-market (GTM) strategy: Workflow integration is non-negotiable (standalone apps struggle). Reimbursement clarity is critical. Regulatory strategy is part of GTM, not an afterthought. Time stamps: 00:06 – Introduction: startups, global markets, and unconventional careers 01:18 – From dental surgery to global public health and digital health 03:05 – The GTM shift: from promise to proof 04:49 – Staying investable: the four pillars 08:22 – AI ROI: clinical vs operational value 12:17 – Enterprise scaling and “sell to the mindset” 15:05 – Responsible AI: transparency, bias, and lifecycle regulation 19:56 – Predictability vs black-box AI in medicine 22:44 – Global innovation differences: Europe, India, Middle East, Africa 26:21 – Pilotitis: why pilots fail to scale 28:40 – Designing pilots for commercialization 30:26 – Capital flows, geopolitics, and reverse innovation 34:25 – The $1 teleconsultation model in India 37:56 – Digital health and equity: design vs digitization 42:43 – How regulators can keep up with AI 46:03 – Advice for Gen Z and Gen Alpha in digital health 48:50 – Grassroots realities shaping policy Watch the full discussion: https://youtu.be/bmvPzz3Ffp4 www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/

Send a textHealthcare access is often treated as a technology problem, but the real barriers run much deeper. Geography, cost, culture, trust, and digital readiness all shape whether patients can actually get the care they need. Without addressing the system as a whole, even the most advanced tools risk leaving people behind.Sarah Matt, Author of The Borderless Healthcare Revolution, joins the HealthBiz Podcast to discuss what it truly takes to break down geographic barriers in healthcare, why access must be designed into systems from the start, and how technology can support care without replacing the human connection at its core. 

“I do not believe we should be testing to test. We have to know, is this test going to change management and is it going to make a difference,” says pediatric allergist-immunologist Dr. Zachary Rubin. His knack for providing that sort of straightforward guidance explains why Dr. Rubin has become a trusted voice on allergies, asthma, and vaccines for his millions of followers on social media platforms. It's also why we couldn't ask for a better guide for our discussion on the rise in allergies, asthma, and immune-related conditions in children, and how families can navigate the quickly evolving science and rampant misinformation in the space. On this episode of Raise the Line, we also preview Dr. Rubin's new book, All About Allergies, in which he breaks down dozens of conditions and diseases, offering clear explanations and practical treatment options for families. Join host Lindsey Smith for this super informative conversation in which Dr. Rubin shares his thoughts on a wide range of topics including: What's behind the rise in allergic and immune-related conditions.Tips for managing misinformation, myths and misunderstandings. How digital platforms can be leveraged to strengthen public health.How to build back public trust in medicine.Mentioned in this episode:All About Allergies bookBench to Bedside PodcastInstagramTikTokYouTube Channel If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; joined Over the Counter to discuss direct-to-patient pharmacy models and how they're revolutionizing the future of health care.

Matt Hampton and Dr Tom Ingegno came into my world the way the best guests always do. They found me first. They pulled me onto their Irreverent Health Podcast, a show that blends medicine, curiosity, and unapologetic nonsense the same way Gen X kids blended Saturday morning cartoons with nuclear-war anxiety. We recorded together, we went off the rails together, and by the end I told them the rule. If you ever come to New York, you sit in my studio. No exceptions.They showed up. They took the hot seat. They told Alexa to shut up. They joked about Postmates. They compared bifocals before I even hit record. From there it turned into a full blown eighties time machine powered by weed policy, AI diagnostics, acupuncture philosophy, art school trauma, cannabis data science, paranormal detours, and the kind of deep cut pop culture references only Gen X survivors can decode.Matt builds AI systems. Tom heals people with needles and a lifetime of East Asian medicine. Together they make healthcare funny without pretending it works. They remind you that curiosity carries weight when the system collapses under its own stupidity.This episode is a reunion of three loudmouths raised on Atari, late night cable, and the hard lesson that you either tell the truth or get flattened by it. Go subscribe to Irreverent Health. These guys earned it.RELATED LINKS• Irreverent Health Podcast• Matt Hampton – Consilium Institute• Envoy Design• Dr. Tom Ingegno – Charm City Integrative Health• The Cupping Book• You Got Sick—Now What?• Matt Hampton on LinkedIn• Dr. Tom Ingegno on LinkedInFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Faces of Digital Health, host Tjasa Zajc sits down with Bart de Witte for a candid conversation on what agent-based AI really means for healthcare. Recorded during a car ride in Ljubljana, the discussion explores why healthcare needs an operating system for AI agents, the risks of agent autonomy, privacy-by-design through on-device AI, and why monolithic EHRs struggle with the next generation of clinical workflows. Bart also shares his vision for open, decentralized AI ecosystems, certified clinical agents, and swarm intelligence and explains why Europe may be uniquely positioned to lead this shift. A practical, forward-looking episode for anyone working at the intersection of healthcare, AI, and digital infrastructure. Youtube video version: https://youtu.be/F_GRfIbqJJM?si=qheSsKvcg6WXUqTU

Physicians now face a world where search bars, chat apps, and large AI models are becoming many people's first stop for health questions, long before they enter a clinic.Former Google Chief Health Officer and national health IT leader Dr. Karen DeSalvo joins us to unpack what this shift means for clinicians, regulators, and patients, and why 15% of daily Google searches are questions no one has ever asked before.We cover:• Why consumer health search is becoming a powerful entry point into care• How Google built guardrails for safety, quality, and real-time monitoring of emerging risks• What the rise of GenAI “doctor in your pocket” tools could mean• The regulatory tensions ahead as states experiment with AI-driven medical decision support• How global demand, workforce strain, and new data sources (IoT, at-home diagnostics, wearables) are accelerating AI-supported primary care—About our guest: Dr. Karen DeSalvo is a health leader who has committed her career to improving health for everyone, everywhere. She was most recently Google's Chief Health Officer, where spearheaded a global team of health professionals dedicated to harnessing Google's technology and platforms to help everyone, everywhere live a longer, healthier life. Before Google, Dr. DeSalvo held significant roles in the U.S. government, including National Coordinator for Health Information Technology and acting Assistant Secretary for Health. She was also the Health Commissioner in New Orleans following Hurricane Katrina, where she led public health recovery efforts. Dr. DeSalvo currently sits on the Boards of Directors for Welltower and CityBlock Health and is a member of the Council of the National Academy of Medicine. —Pre-order Halle's new book, Massively Better Healthcare.—

Desmond Patton is the 31st PIK University Professor at the University of Pennsylvania, with joint appointments in the School of Social Policy & Practice and the Annenberg School for Communication, where he is the Waldo E Johnson Jr. Professor of Communication. He also holds secondary appointments in the Department of Psychiatry at Children's Hospital of Philadelphia & Perelman School of Medicine. He is founding director of SAFElab, founding faculty director of the Penn Center for Inclusive Innovation & Technology, and Chief Strategy Officer for the School of Social Policy & Practice.Professor Patton's groundbreaking research examines the relationship between social media and gun violence, grief, and loss, focusing on how online communities influence offline behavior. His work has made him the most cited and widely recognized scholar in this critical area of social science. Early research focused on detecting trauma and preventing violence on social media has evolved into broader investigations of language analysis and algorithmic bias in artificial intelligence. He currently serves as a member of Spotify's Safety Advisory Council, the Ethics and Equity Advisory Council (EEAC) at Axon, TikTok's U.S. Content Advisory Council, and is a trusted advisor to several AI startups.As a social work scientist, Patton identified that traditional data science methods often fail to capture the cultural and linguistic nuances of predominantly Black and Hispanic youth. In response, he developed the Contextual Analysis of Social Media (CASM) framework, which integrates culture, context, and inclusion into machine learning and computer vision analysis. He is also pioneering a new research agenda on joy, developing a practical and theoretical framework for integrating joy into AI model development as a tool for equity, imagination, and human connection.Dr. Patton is a member of the National Academy of Medicine, an Obama Foundation USA Leader, a Mozilla Rise 25 Change Agent, a Presidential Leadership Scholar, and one of RockHealth's Top 50 in Digital Health.Links:https://sp2.upenn.edu/person/desmond-upton-patton/https://bsky.app/profile/did:plc:dxheqqkccc6z5kqgw34shta7https://www.linkedin.com/in/desmond-patton-49a7b59/ Hosted on Acast. See acast.com/privacy for more information.

AI Wins in Healthcare: Administrative Automation, Revenue Cycle, and the Future of Intelligent Care Healthcare administrative costs consume 25-30% of total spending, yet most AI investments focus on clinical applications rather than operational efficiency. Dr. Yan Chow of Automation Anywhere discusses proven AI use cases delivering measurable ROI today, from revenue cycle management and EOB processing to automated clinical documentation while exploring emerging conversational AI capabilities reshaping patient and provider interactions. As health systems face continued margin pressure, Chow examines where automation investments generate immediate returns versus longer-term strategic value. He addresses the “art of the possible” in administrative AI, implementation realities for enterprise deployments, and why the next wave of healthcare AI may be less about diagnosis and more about eliminating the administrative burden strangling clinical workflows. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast